Join Servier CDMO at CPhI North America 2018

by Servier CDMO
News, CPhI North America

Servier CDMO will be exhibiting at CPhI North America in Philadelphia, PA from April 24-26, 2018.

We would value the opportunity to meet at the show and discuss how we can help to advance your next project.

Contact us at to schedule a meeting.

Reducing Time to Market with Targeted Regulatory Affairs Support

Regulatory affairs activities are essential components of any drug development and commercialization program. CDMOs with extensive experience with product approvals that have regulatory affairs deeply integrated with other operational teams can provide optimized regulatory strategies.

Corporate Social Responsibility as a Driver for Improved Sustainability

 The pharmaceutical industry must respond to growing expectations for product safety, the conduct of clinical trials, access to therapeutic care and the environmental impact of medicinal products and manufacturing. Servier Group formalized its Corporate Social Responsibility (CSR) strategy to integrate and communicate the actions it is taking in collaboration with internal and external stakeholders.

Shire Announces Sale of Oncology Business to Servier for $2.4 Billion

Servier Group is proud to announce that it will develop its presence in the US market through the oncology therapeutic area. Servier CDMO, in accordance with the group’s strategy, continues to develop its services for High Potent drugs in API and drug product.